Home

I WISTAR MORRIS III

CIK 898242 · last filed 2020-10-08

I WISTAR MORRIS III is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing, for IMNM, was dated Oct 8, 2020. Across all open-market trades the lifetime net is +$424.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.1M across reported positions. 3 SEC filings were submitted jointly with ELITE PHARMACEUTICALS INC /NV/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.09M

Companies

2

Total Filings

4

Lifetime Open-Market Net

$424.6K

Filer Profile

Reported Address
4 TOWER BRIDGE, STE 300
200 BARR HARBOR DRIVE
WEST CONSHOHOCKEN, PA 19428
Related Filers
ELITE PHARMACEUTICALS INC /NV/ — 3 joint filings, latest 2011-05-24
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMNM 10%+ Owner 920,939 $25.07 $23.09M $0 1 2020-10-08
MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Director 1,262,099 — — $424.6K 3 2012-08-21

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-10-08 IMNM Conv (C) +920,939 $0 EDGAR
2012-08-21 MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Exer (M) +2,500 $19.1K EDGAR
2012-03-22 MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Grant (A) — $0 EDGAR
2012-02-10 MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Buy (P) +70,766 $424.6K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.